Skip to main content

Medifast Inc

corporate_fare Company Profile

Medifast Inc

MED·NYSE·Manufacturing·CIK 0000910329

Medifast, Inc. is a health and wellness company with over 40 years of experience, known for its science-backed, coach-guided lifestyle system. As of 2026, the company is focusing on execution, using its experience in structured weight loss and recent scientific research and product enhancements to serve the broader metabolic health market. Medifast addresses the root cause of metabolic dysfunction. This strategy targets a larger and more sustainable market, aiming for long-term growth over the next decade by aligning science, products, and coaching with increasing demand for solutions as awareness of metabolic dysfunction grows. This growth is supported by improving coach productivity and expanding the coach network. The company operates a well-capitalized business with a lifestyle solution and a business model that has impacted over 3 million lives. For the quarter ended December 31, 2025, Medifast had a network of approximately 16,100 active earning independent coaches. Medifast offers evidence-based wellness solutions, and its coach-first model creates opportunities for coaches' individual businesses. This model is designed to create a "flywheel effect" where new clients join, increasing coach productivity, which attracts new active earning coaches, leading to more new clients and further productivity. The company provides a comprehensive approach to achieving optimal metabolic health and well-being, empowering individuals to make lasting changes. Clients are guided by coaches, approximately 90% of whom were clients first, through their wellness journey. Scientifically developed products and a habit creation framework, reinforced by coaches and community support, provide health benefits and serve as a foundation for a comprehensive metabolic health system. Medifast innovates based on its scientific and clinical heritage to achieve its mission of Lifelong Transformation, Making a Healthy Lifestyle Second Nature®. Coaches provide support, community, nutrition, and healthy habits.

Medifast Inc (NYSE:MED) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 20 items for MED at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for MED spans 4, SCHEDULE 13D/A, 10-Q, 8-K.

Recent high-impact activity:

  • Director Kiai Parsa Adds $529K More in Medifast Stock, Extending Accumulation Streak
  • Steamboat Capital Partners Reveals 7.1% Medifast Stake After $8.4M Buying Spree
  • Director Kiai Parsa Buys $842,699 of Medifast Stock
  • Medifast Q2 Revenue Drops 28%, Loss Widens as Coach Exodus Continues
  • Medifast Q2 Revenue Drops 28%, Loss Deepens; Full-Year Loss Guidance Issued

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$385.79M
Net Income
-$18.67M
Diluted EPS
-$1.70
Op. Cash Flow
$6.86M
Free Cash Flow
$1.25M
Gross Profit
$275.19M
Operating Income
-$14.21M
Cash & Equivalents
$89.3M
Debt / Equity
0.00×
Net Margin
-4.8%
Shares Outstanding
10.99M sh
Source: 10-K · filed 2026-02-17 · accession 0001628280-26-008656

Short Interest & Short Volume

20.02 days to cover

FINRA reported short interest of 1,862,070 shares in MED as of the September 15, 2026 settlement, a 1.1% decrease from the prior period — about 20.0 days to cover at its recent average daily volume. On October 2, 2026, 64.7% of MED volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,862,070 shares as of September 15, 2026
Change vs prior period▼ 1.1%
Days to cover20.02 at avg daily volume of 93,002
Daily short volume (FINRA facilities)64.7% of 34,256 shares on October 2, 2026
5-day average short volume47.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$11.73
52-week range · as of 2026-08-28 $9.22 – $14.67
Market cap
$131.15M
Volume
82.6K (0.7× avg)
3-mo avg 120.1K
Live data · 2026-10-03 15:15 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MED - Latest Insights

MED
Aug 28, 2026, 12:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.95
Real-time Price: $11.73 info
Change: -$0.220 (-2%) info
Market Cap: $131.15M info
MED
Aug 21, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $11.95
Real-time Price: $11.73 info
Change: -$0.220 (-2%) info
Market Cap: $131.15M info
MED
Aug 21, 2026, 12:35 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.56
Real-time Price: $11.73 info
Change: +$0.170 (+1%) info
Market Cap: $131.15M info
MED
Aug 03, 2026, 4:50 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.80
Real-time Price: $11.73 info
Change: -$1.07 (-8%) info
Market Cap: $131.15M info
MED
Aug 03, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.78
Real-time Price: $11.73 info
Change: +$0.950 (+9%) info
Market Cap: $131.15M info
MED
Jun 01, 2026, 9:03 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.19
Real-time Price: $11.73 info
Change: -$1.46 (-11%) info
Market Cap: $131.15M info
MED
Jun 01, 2026, 8:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.19
Real-time Price: $11.73 info
Change: -$1.46 (-11%) info
Market Cap: $131.15M info
MED
May 26, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.09
Real-time Price: $11.73 info
Change: -$1.36 (-10%) info
Market Cap: $131.15M info
MED
May 04, 2026, 4:51 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.73 info
Change: +$0.730 (+7%) info
Market Cap: $131.15M info
MED
May 04, 2026, 4:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.73 info
Change: +$0.730 (+7%) info
Market Cap: $131.15M info
MED
May 04, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.63
Real-time Price: $11.73 info
Change: +$1.10 (+10%) info
Market Cap: $131.15M info
MED
May 04, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $11.73 info
Change: +$0.730 (+7%) info
Market Cap: $131.15M info
MED
Apr 30, 2026, 9:24 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $10.88
Real-time Price: $11.73 info
Change: +$0.855 (+8%) info
Market Cap: $131.15M info
MED
Apr 06, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $10.52
Real-time Price: $11.73 info
Change: +$1.21 (+12%) info
Market Cap: $131.15M info
MED
Mar 27, 2026, 5:51 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $9.99
Real-time Price: $11.73 info
Change: +$1.74 (+17%) info
Market Cap: $131.15M info
MED
Mar 20, 2026, 12:55 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $10.04
Real-time Price: $11.73 info
Change: +$1.69 (+17%) info
Market Cap: $131.15M info
MED
Mar 20, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.07
Real-time Price: $11.73 info
Change: +$1.66 (+16%) info
Market Cap: $131.15M info
MED
Feb 17, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $10.40
Real-time Price: $11.73 info
Change: +$1.33 (+13%) info
Market Cap: $131.15M info
MED
Feb 17, 2026, 4:44 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.40
Real-time Price: $11.73 info
Change: +$1.33 (+13%) info
Market Cap: $131.15M info
MED
Jan 05, 2026, 9:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.40
Real-time Price: $11.73 info
Change: +$1.33 (+13%) info
Market Cap: $131.15M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets